X-Chem is a leader in small molecule drug discovery services for pharmaceutical and biotech companies.
Our medicinal chemistry team brings decades of experience to bear in progressing hits into feasible candidates, borne out in the number of development programs we’ve put forward for our
read morepartners. With experience spanning the gamut of chemotypes and applications, whether it be synthesizing an array of bispecific degraders or scouting scale-up routes for a development candidate, our clients rely on us to solve their most difficult and IP-sensitive discovery challenges.
As pioneers of DNA-encoded chemical library (DEL) technology, the company leverages its market-leading DEL platform to discover novel small molecule leads against challenging, high-value therapeutic targets, screening billions of drug-like compounds and returning validated hits within 6 months. Paired with our medicinal chemists, X-Chem can take progress those leads with unmatched speed. X-Chem’s ArtemisAI platform is a means-tested ML platform available to further accelerate all steps in the process. X-Chem also provides DEL and non-DEL libraries, reagents/building blocks, and informatic tools to allow DEL operators to get the most of their DEL platform.
X-Chem empowers its partners to effectively build drug pipelines from target to clinical candidate, enhanced with AI.
